Low MOQ for Covid Results - SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit – Yinye
Low MOQ for Covid Results - SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit – Yinye Detail:
REF | 510010 | Specification | 96 Tests/Box |
Detection principle | PCR | Specimens | Nasal / Nasopharyngeal swab / Oropharyngeal swab |
Intended Use |
StrongStep® SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit is intended for simultaneous qualitative detection and differentiation of SARS-CoV-2,Influenza A virus and Influenza B virus RNA in healthcare provider-collected nasal and nasopharyngeal swab or oropharyngeal swab specimens and self-collected nasal or oropharyngeal swab specimens(collected in a healthcare setting with instruction by a healthcare provider) from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider. |
The kit is intended for use by laboratory trained personnel
StrongStep® SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit is intended for simultaneous qualitative detection and differentiation of SARS-CoV-2,Influenza A virus and Influenza B virus RNA in healthcare provider-collected nasal and nasopharyngeal swab or oropharyngeal swab specimens and self-collected nasal or oropharyngeal swab specimens(collected in a healthcare setting with instruction by a healthcare provider) from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider. RNA from SARS-CoV-2, influenza A, and influenza B is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2, influenza A, and/or influenza B RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease. Negative results do not preclude infection from SARS-CoV-2, influenza A, and/or influenza B and should not be used as the sole basis for treatment or other patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. StrongStep® SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR assays and in vitro diagnostic procedures.
Product detail pictures:
Related Product Guide:
Our solutions are widely recognized and trusted by consumers and will meet up with constantly developing financial and social requires for Low MOQ for Covid Results - SARS-CoV-2 & Influenza A/B Multiplex Real-Time PCR Kit – Yinye , The product will supply to all over the world, such as: UK, Manchester, Namibia, As operation principle is "be market-oriented , good faith as principle, win-win as objective", holding on "customer first, quality assurance, service first" as our purpose, dedicated to provide the original quality, create excellence service , we won the praise and trust in the industry of auto parts. In the future, We will provide quality product and excellent service in return to our customers , welcome any suggestions and feedback from all over the world.
By Ivy from Germany - 2018.09.16 11:31
We always believe that the details decides the company's product quality, in this respect, the company conform our requirements and the goods are meet our expectations.
By Riva from Guyana - 2018.11.06 10:04